Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS

NCT03334786 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Development of Current Formulation has Ceased

Conditions

Amyotrophic Lateral Sclerosis
Fasciculation

Interventions

DRUG: FLX-787-ODT

Sponsor

Flex Pharma, Inc.